Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
Paola Ciciola(University of Naples Federico II), Roberto Bianco(Federico II University Hospital)
Cited by 105
Related Papers
Mechanisms of lapatinib resistance in HER2-driven breast cancer
|Cancer Treatment Reviews|2015|162
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers
|British Journal of Cancer|2017|99
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models
|British Journal of Cancer|2014|86
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
|British Journal of Cancer|2014|58